Traitements2programmes
Essais1liés
Publications6liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
Brivaracetam (ucb34714)The primary objective of this Phase I study in 15 adult subjects suffering from epilepsy and chronically treated with phenytoin monotherapy is to evaluate the effect of steady-state ucb 34714 administration on the steady-state plasma levels of phenytoin. Épilepsie Phase 1 À vérifier United States À vérifier
Brivaracetam (ucb34714)The primary objective of this Phase I study in 15 adult subjects suffering from epilepsy and chronically treated with phenytoin monotherapy is to evaluate the effect of steady-state ucb 34714 administration on the steady-state plasma levels of phenytoin. Épilepsie Phase 1 À vérifier United States À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
Brivaracetam (ucb34714) Épilepsie Phase 1 NCT00426673 An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy. COMPLETED

Publications

6
MoléculeIndication / populationTitreJournalDate
Brivaracetam (ucb34714) Eco-friendly MIP-based electrochemical sensor for selective detection of brivaracetam in plasma. Analytical and bioanalytical chemistry
Brivaracetam (ucb34714) Characterization, healthcare resource utilization, and costs of health equity clusters of Medicaid-insured patients with epilepsy: An exploratory machine learning approach. Epilepsy research
Brivaracetam (ucb34714) Antiseizure medication dosing and monitoring in the intensive care unit: a practical narrative review. Intensive care medicine
Brivaracetam (ucb34714) Trends in antiseizure medication use among women of childbearing age with epilepsy. Journal of the neurological sciences
Brivaracetam (ucb34714) Anti-seizure medication in Germany over 25 years: trends in prices and prescription patterns from national data from 2000 to 2024. Epilepsy & behavior : E&B
Brivaracetam (ucb34714) Brivaracetam as viable monotherapy option for focal and generalized epilepsy. Epilepsy & behavior : E&B